EBS | Emergent BioSolutions Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31
Revenue	1.05B	1.12B	1.79B	1.56B	1.11B	782.40M	560.87M	488.78M	522.79M	450.14M	312.75M	281.89M	273.38M	286.17M	234.79M	178.55M	182.91M	152.73M	130.69M	83.49M	55.77M	78.54M	45.31M
Cost of Revenue	756.80M	693.70M	757.50M	524.00M	433.50M	322.30M	195.71M	131.28M	124.30M	118.41M	62.13M	46.08M	42.17M	47.11M	46.26M	34.08M	40.31M	24.12M	31.60M	30.10M	N/A	24.57M	N/A
Gross Profit	292.50M	427.20M	1.04B	1.03B	672.50M	460.10M	365.17M	357.50M	398.49M	331.73M	250.62M	235.81M	231.21M	239.06M	188.52M	144.47M	142.61M	128.61M	99.08M	53.39M	N/A	53.97M	N/A
Operating Expenses	464.50M	593.20M	640.90M	597.60M	558.40M	370.30M	240.88M	251.98M	302.45M	273.67M	207.82M	196.24M	199.11M	165.50M	148.37M	114.55M	109.51M	90.10M	51.17M	40.44M	N/A	16.20M	N/A
Selling, General & Admin	356.70M	340.30M	348.40M	303.30M	273.50M	202.50M	143.50M	143.69M	148.46M	122.84M	87.88M	76.02M	74.28M	76.20M	73.79M	55.08M	55.55M	44.60M	42.79M	30.32M	N/A	13.40M	N/A
Research & Development	107.80M	193.00M	234.00M	234.50M	226.20M	142.80M	97.38M	108.29M	154.00M	150.83M	119.93M	120.23M	124.83M	89.30M	74.59M	59.47M	53.96M	45.50M	18.38M	10.12M	N/A	2.81M	N/A
Other Operating Expenses	8.90M	59.90M	58.50M	59.80M	58.70M	1.60M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-10.00M	N/A	N/A	N/A	N/A
Operating Income	-172.00M	-166.00M	352.60M	433.80M	114.10M	89.80M	124.28M	105.52M	96.04M	58.06M	42.80M	29.97M	32.10M	73.56M	40.15M	29.93M	33.09M	38.03M	21.34M	16.77M	55.77M	37.77M	-364.00K
Other Expenses / Income	-559.20M	-55.70M	-38.20M	-26.60M	-36.70M	1.60M	-5.65M	-6.30M	-6.27M	-4.99M	565.00K	2.10M	-156.00K	-191.00K	1.36M	2.81M	2.89M	-13.00K	-227.00K	-170.00K	N/A	-642.00K	-190.00K
Before Tax Income	-731.20M	-221.70M	314.40M	407.20M	77.40M	81.50M	118.63M	99.22M	89.77M	53.06M	43.37M	32.06M	31.94M	73.37M	41.51M	32.74M	35.99M	38.02M	21.11M	16.60M	N/A	37.12M	-554.00K
Income Tax Expenses	29.30M	2.10M	83.50M	102.10M	22.90M	18.80M	36.04M	36.70M	26.90M	16.32M	13.11M	13.92M	15.83M	26.18M	14.97M	12.05M	13.05M	15.22M	5.33M	5.13M	N/A	733.00K	N/A
Net Income	-760.50M	-223.80M	219.50M	305.80M	54.50M	62.70M	82.59M	51.78M	62.87M	36.74M	31.14M	23.52M	23.02M	51.70M	31.14M	20.68M	22.94M	22.79M	15.78M	11.47M	4.45M	36.39M	-554.00K
Interest Expenses	96.80M	37.30M	34.50M	31.30M	38.40M	9.90M	6.59M	7.62M	6.52M	8.24M	N/A	6.00K	N/A	N/A	7.00K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	51.20M	50.10M	53.50M	52.70M	51.50M	51.40M	41.82M	40.18M	38.60M	37.34M	36.20M	36.08M	35.66M	31.78M	30.44M	29.84M	29.00M	23.04M	20.53M	18.92M	18.90M	18.47M	18.47M
Diluted Shares Outstanding	51.20M	50.10M	54.10M	53.80M	52.40M	51.40M	50.33M	49.34M	47.26M	45.80M	36.75M	36.42M	36.21M	32.54M	31.38M	30.46M	29.66M	24.57M	22.75M	20.44M	20.32M	20.80M	18.47M
EBITDA	-42.90M	-34.40M	514.40M	553.00M	226.50M	116.40M	167.79M	134.32M	131.63M	93.75M	63.20M	48.65M	48.20M	83.87M	51.12M	37.70M	40.80M	42.73M	24.66M	18.47M	4.45M	37.12M	-554.00K
EBITDA Margin	-4.09%	-3.07%	28.69%	35.55%	20.48%	14.88%	29.92%	27.48%	25.18%	20.83%	20.21%	17.26%	17.63%	29.31%	21.77%	21.11%	22.31%	27.98%	18.87%	22.12%	7.99%	47.27%	-1.22%
EBIT	-634.40M	-184.40M	337.50M	439.20M	115.80M	91.40M	125.22M	96.09M	96.29M	61.30M	44.24M	37.45M	38.85M	77.88M	46.12M	32.74M	35.99M	38.02M	21.11M	16.60M	4.45M	37.12M	-554.00K
EBIT Margin	-60.46%	-16.45%	18.83%	28.24%	10.47%	11.68%	22.33%	19.66%	18.42%	13.62%	14.15%	13.29%	14.21%	27.21%	19.64%	18.33%	19.67%	24.89%	16.15%	19.88%	7.99%	47.27%	-1.22%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31